Clinical trial
CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation
NCT00422435 · Conor Medsystems, Industry · Completed
Key facts
| NCT number | NCT00422435 |
|---|---|
| Title | CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation |
| Official title | The PreCiSE Trial: CoStar™ Paclitaxel-Eluting Coronary Stent Catheter System Evaluation |
| Lead sponsor | Conor Medsystems, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | CoStar™ Paclitaxel-Eluting Coronary Stent with SRX catheter |
| Enrollment | 107 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Jan 17, 2007 |
| Last update posted | Oct 24, 2008 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: